Actualités Gsk Plc - GSK | Actions London Stock Exchange

Outils de qualité professionnelle, pour des investisseurs individuels.

GSK PLC Director/PDMR Shareholding

GSK PLC 23 December 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a...

GSK PLC Block Listing Application

GSK PLC 20 December 2024 GSK plc Block listing Application Application has been made to the Financial Conduct Authority and the London...

GSK reports mixed findings from ovarian cancer phase III study

GSK PLC on Friday said a trial of two ovarian cancer treatments met its primary endpoint but did not meet a key secon ...

GSK PLC Headline results from phase III FIRST trial

GSK PLC 20 December 2024 Issued: 20 December 2024, London UK GSK announces FIRST trial met its primary endpoint of progression free survival...

GSK receives three positive regulatory updates on cancer products

GSK PLC on Monday reported a triple dose of good news with positive regulatory updates on two leading cancer drugs. ...

GSK PLC Jemperli receives US FDA breakthrough designation

GSK PLC 16 December 2024 Issued: 16 December 2024, London UK Jemperli (dostarlimab) receives US FDA Breakthrough Therapy Designation for...

GSK PLC EMA grants PRIME Designation for GSK’227

GSK PLC 16 December 2024 Issued: 16 December 2024, London UK GSK's B7-H3-targeted antibody-drug conjugate, GSK'227, receives EMA Priority...

GSK PLC Jemperli receives positive CHMP opinion

GSK PLC 16 December 2024 Issued: 16 December 2024, London UK Jemperli (dostarlimab) plus chemotherapy receives positive CHMP opinion to...

GSK PLC Director/PDMR Shareholding

GSK PLC 12 December 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA...

IN BRIEF: GSK highlights positive Blenrep data from Dreamm-7 trial

based pharmaceuticals firm - Says Dreamm-7 trial shows sustained overall survival benefit for Blenrep, the brand name ...

GSK PLC Overall survival data presented for Blenrep

GSK PLC 09 December 2024 Issued: 9 December 2024, London UK Blenrep shows significant overall survival benefit, reducing the risk of death...

GSK's Nucala and Blenrep receive regulatory boost in US and China

GSK PLC on Monday received a double-dose of good news with its Nucala and Blenrep products receiving positive indicat ...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Gsk Plc (GSK)

Outils de qualité professionnelle, pour des investisseurs individuels.

GSK Actualités

GSK PLC Director/PDMR Shareholding

GSK PLC Block Listing Application

GSK reports mixed findings from ovarian cancer phase III study

GSK PLC Headline results from phase III FIRST trial

GSK receives three positive regulatory updates on cancer products

GSK PLC Jemperli receives US FDA breakthrough designation

GSK PLC EMA grants PRIME Designation for GSK’227

GSK PLC Jemperli receives positive CHMP opinion

GSK PLC Director/PDMR Shareholding

IN BRIEF: GSK highlights positive Blenrep data from Dreamm-7 trial

GSK PLC Overall survival data presented for Blenrep

GSK's Nucala and Blenrep receive regulatory boost in US and China

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Gsk Plc (GSK) Actualités

Gsk Plc (GSK)

Outils de qualité professionnelle, pour des investisseurs individuels.

GSK Actualités

GSK PLC Director/PDMR Shareholding

GSK PLC Block Listing Application

GSK reports mixed findings from ovarian cancer phase III study

GSK PLC Headline results from phase III FIRST trial

GSK receives three positive regulatory updates on cancer products

GSK PLC Jemperli receives US FDA breakthrough designation

GSK PLC EMA grants PRIME Designation for GSK’227

GSK PLC Jemperli receives positive CHMP opinion

GSK PLC Director/PDMR Shareholding

IN BRIEF: GSK highlights positive Blenrep data from Dreamm-7 trial

GSK PLC Overall survival data presented for Blenrep

GSK's Nucala and Blenrep receive regulatory boost in US and China

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application